my account
Login
  Loading... Please wait...

Neurodegeneration

Neurodegeneration is a progressive deterioration of neuronal structures and function that ultimately leads to cognitive disability, dementia, and/or motor defects depending on the affected area of the brain. Neurodegenerative disorders can be caused by genetic mutations, aggregation of misfolded proteins, accumulation of toxic intracellular proteins, organelle membrane damage, and mitochondrial dysfunction. Common disorders include multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.

View All Neurodegeneration Reagents

Alzheimer's

  • PNU 282987

    Potent and selective a7 nAChR agonist

  • N-Eicosanoyl serotonin

    Natural product that prevents Aβ-induced impairments in a mouse model of Alzheimer's

  • FPS-ZM1

    FPS-ZM1 Is a high -affinity RAGE receptor antagonist

  • ABT-418

    Neuronal nicotinic receptor agonist that improves cognition in Alzheimer's patients

View All Alzheimer's Reagents

Multiple Sclerosis

  • MDL29,951

    MDL29,951 is a GPR17 activator

  • RIPA-56

    RIP1 kinase inhibitor that blocked progression of multiple sclerosis in an immune-induced demyelination model

  • Benztropine mesylate

    Centrally acting M1 muscarinic acetylcholine receptor antagonist that induces remyelination of neurons

  • FTY720 HCl

    Clinically useful multiple sclerosis drug that is a sphingosine-1-phosphate receptor modulator

View All Multiple Sclerosis Reagents

Parkinson's

  • Terguride

    Terguride is a partial dopamine D2 and serotonin 5HT2B/2C antagonist

  • Rasagiline mesylate

    Potent and irreversible MAO-B inhibitor

  • MPEP HCl

    MPEP is a potent mGlu5 receptor antagonist

  • Entacapone

    Entacapone is a catechol O-methyltransferase inhibitor that increases the bioavailability of L-DOPA

View All Parkinson's Reagents

Amyotrophic lateral sclerosis

  • Pridopidine

    Sigma-1 ligand that ameliorates the central features of ALS

  • Riluzole

    Sodium channel blocker used in the treatment of ALS

  • P7C3

    P7C3 delays disease progression in the G93A-SOD2 mutant mouse model of ALS

  • WHI-P131

    WHI-P131 is a JAK3 inhibitor that increases survival in a mouse model of ALS

View All Amyotrophic lateral sclerosis Reagents

Stem Cells

  • ISX9

    Promotes neurogenesis by enhancing the proliferation and differentiation of neuroblasts

  • Neurodazine

    Induces neurogenesis of non-pluripotent myoblasts

  • Neuropathiazol

    Induces neuronal differentiation of multipotent hippocampal neural progenitor cells

View All Stem Cell Reagents

Neuroinflammation

  • Leonurine

    Inhibits microglial activation via JNK and NFk-B pathways

  • Synaptamide

    Endogenous GPR110 agonist that ameliorates LPS-induced neuroinflammation in a mouse model

  • C-DIM 12

    C-DIM 12 activates the orphan receptor Nurr1 and displays strong neuroinflammatory inhibition

View All Neuroinflammation Reagents

Focus BiomoleculesPlymouth Meeting, PA USA1-855-FOCUS21

Connect with Focus